Review decisions

Showing 1940 results of 2199 total
Summary Safety Review - Imuran (azathioprine) - Serious Brain Infection (Progressive Multifocal Leukoencephalopathy)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00053
Issued / Original Publication Date: 2014-09-30
Summary Safety Review - AVASTIN (bevacizumab) and LUCENTIS (ranibizumab) - Thrombotic Microangiopathy
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00054
Issued / Original Publication Date: 2014-09-29
Summary Basis of Decision for Zerbaxa
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00247
Product Type: Drug
Control Number: 178006
DIN(s): 02446901
Manufacturer: Merck Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2014-09-15
Issued / Original Publication Date: 2015-11-30
Decision / Authorization Date: 2015-09-30
Updated Date: 2023-03-30
Summary Basis of Decision for Aptiom
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00271
Product Type: Drug
Control Number: 165665
DIN(s): 02426862, 02426870, 02426889, 02426897
Manufacturer: Sunovion Pharmaceuticals Canada Inc.
Submission Type: New Drug Submission
Issued / Original Publication Date: 2014-08-29
Updated Date: 2020-03-09
Summary Safety Review - Interferon-beta Products - Thrombotic Microangiopathy
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00055
Issued / Original Publication Date: 2014-08-22
Summary Basis of Decision for Varithena
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00245
Product Type: Drug
Control Number: 177359
DIN(s): 02444267
Manufacturer: Provensis Ltd.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2014-08-20
Issued / Original Publication Date: 2015-09-18
Decision / Authorization Date: 2015-08-04
Updated Date: 2023-01-11
Summary Basis of Decision for Obizur
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00240
Product Type: Drug
Control Number: 177290
DIN(s): 02447401
Manufacturer: Baxalta Canada Corporation
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2014-08-15
Issued / Original Publication Date: 2015-12-03
Decision / Authorization Date: 2015-10-14
Updated Date: 2024-02-20
Summary Safety Review - NEUPOGEN (filgrastim) and NEULASTA (pegfilgrastim) - Capillary Leak Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00056
Issued / Original Publication Date: 2014-07-29
Summary Safety Review - Topical Antiseptic Products - Risk of Infection
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00057
Issued / Original Publication Date: 2014-07-25
Summary Basis of Decision for Firazyr
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00218
Product Type: Drug
Control Number: 162918
DIN(s): 02425696
Manufacturer: Shire Orphan Therapies Inc.
Submission Type: New Drug Submission
Issued / Original Publication Date: 2014-07-16
Updated Date: 2016-02-19

Displaying 1931 - 1940 of 2199 | Page 194 of 220
Report a problem or mistake on this page
Please select all that apply:
Date modified: